Skip to search formSkip to main contentSkip to account menu

Malignant mesothelioma

Known as: Malignant Mesothelial Neoplasm, Malignant Tumor of Mesothelium, Malignant Mesothelial Tumor 
A rare type of cancer in which malignant cells are found in the sac lining the chest or abdomen. Exposure to airborne asbestos particles increases… 
National Institutes of Health

Related topics

Related topics

29 relations

Narrower (11)

Adenomatoid TumorBiphasic MesotheliomaDiffuse malignant mesotheliomaMalignant Mesothelioma of Peritoneum
CDISC SEND Tumor Findings Results TerminologyCDKN2A geneCDKN2A wt AlleleClinical Data Interchange Standards Consortium Terminology

Broader (5)

Lung NeoplasmsNeoplasm, uncertain whether benign or malignantNeoplasmsRespiration Disorders

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group.
CONTEXT - Malignant mesothelioma (MM) is an uncommon tumor that can be difficult to diagnose. OBJECTIVE - To provide updated… 
Highly Cited
2015
Highly Cited
2015
High Incidence of Somatic BAP1 Alterations in Sporadic Malignant Mesothelioma
Background: Breast cancer 1-associated protein 1 (BAP1) is a nuclear deubiquitinase that regulates gene expression, transcription… 
Review
2013
Review
2013
Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group.
CONTEXT Malignant mesothelioma (MM) is an uncommon tumor that can be difficult to diagnose. OBJECTIVE To provide updated… 
Highly Cited
2011
Highly Cited
2011
Germline BAP1 mutations predispose to malignant mesothelioma
Because only a small fraction of asbestos-exposed individuals develop malignant mesothelioma, and because mesothelioma clustering… 
Highly Cited
2009
Highly Cited
2009
Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group.
CONTEXT Malignant mesothelioma (MM) is an uncommon tumor that can be difficult to diagnose. OBJECTIVE To develop practical… 
Review
2001
Review
2001
Management of malignant pleural effusions.
⇓Malignant pleural effusions are a common clinical problem in patients with neoplastic disease. In one post mortem series… 
Highly Cited
2001
Highly Cited
2001
Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma
Vascular endothelial growth factor (VEGF), a potent mitogen for vascular endothelium, is expressed in malignant pleural… 
Highly Cited
1995
Highly Cited
1995
Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy.
The purpose of this randomized prospective study was to assess the efficacy of local radiotherapy in preventing malignant seeding… 
Highly Cited
1994
Highly Cited
1994
p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma.
To determine whether p16 is altered in human malignant mesothelioma (MM), molecular analysis of multiple 9p loci was performed on… 
Review
1992
Review
1992
Latent period for malignant mesothelioma of occupational origin.
To estimate the minimal latent period for malignant mesothelioma of occupational origin, we reviewed 21 articles that documented… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)